Clinical Trial Update: Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia [Phase 4]

View source ↗

Summary

This entry describes a Phase 4 protocol for infusing Buffy Coat-derived cryopreserved platelets to treat severe thrombocytopenia; the trial status is terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Thrombocytopenia

Drugs mentioned

• Buffy Coat-derived Cryopreserved Platelets (cryopreserved platelets derived from buffy coat)

Snippet

Sponsor: Napolitano Mariasanta | Conditions: Thrombocytopenia, Primary Thrombocytopenia,Unspecified | Phase 4 | Status: TERMINATED